URI
60
-6
HIG
66
2
BEN
50
9
HSY
31
-6
ORCL
63
-4
ED
45
3
UNH
57
-2
DHI
44
-3
SNA
70
-5
AN
50
-5
THC
60
-5
REGN
38
-2
LMT
30
-2
MCHP
34
-2
GE
61
-3
JWN
48
-2
CI
45
-3
HRB
59
2
PEP
39
-9
NVDA
52
-5
URI
60
-6
HIG
66
2
BEN
50
9
HSY
31
-6
ORCL
63
-4
ED
45
3
UNH
57
-2
DHI
44
-3
SNA
70
-5
AN
50
-5
THC
60
-5
REGN
38
-2
LMT
30
-2
MCHP
34
-2
GE
61
-3
JWN
48
-2
CI
45
-3
HRB
59
2
PEP
39
-9
NVDA
52
-5
Financhill
Back

FlexShares Intl Qual Div ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
55

IQDF
FlexShares Intl Qual Div ETF

Last Price:
24.49
Seasonality Move:
2.48%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
55
FlexShares Intl Qual Div ETF (IQDF) is a Buy

Is FlexShares Intl Qual Div ETF a Buy, Sell or Hold?

  • The current FlexShares Intl Qual Div ETF [IQDF] share price is $24.39. The Score for IQDF is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • IQDF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IQDF Stock Price Chart

What is FlexShares Intl Qual Div ETF's stock price today?

  • The FlexShares Intl Qual Div ETF share price today is $24.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IQDF is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

IQDF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 33.65 Sell
Chaikin Money Flow: -4639 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.89 - 25.79) Sell
Bollinger Bands (100): (24.78 - 25.9) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

IQDF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.89 Sell
20-day SMA: 25.2 Sell
50-day SMA: 25.58 Sell
200-day SMA: 24.84 Sell
8-day EMA: 24.78 Sell
20-day EMA: 25.13 Sell
50-day EMA: 25.37 Sell
200-day EMA: 24.75 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

FlexShares Intl Qual Div ETF Earnings Growth & IQDF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

FlexShares Intl Qual Div ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):